Major Depressive Disorder With Psychotic Features

SEP 8, 2026 · PHASE 3 TRIAL

Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy

ClinicalTrials.gov

This is a Phase 3 trial registration with no results reported; the study is not yet recruiting, so evidence on efficacy and safety cannot be assessed.